Thor Petersen

7.8k total citations
118 papers, 3.5k citations indexed

About

Thor Petersen is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, Thor Petersen has authored 118 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Pathology and Forensic Medicine, 27 papers in Rheumatology and 23 papers in Neurology. Recurrent topics in Thor Petersen's work include Multiple Sclerosis Research Studies (53 papers), Urinary Bladder and Prostate Research (14 papers) and Systemic Lupus Erythematosus Research (12 papers). Thor Petersen is often cited by papers focused on Multiple Sclerosis Research Studies (53 papers), Urinary Bladder and Prostate Research (14 papers) and Systemic Lupus Erythematosus Research (12 papers). Thor Petersen collaborates with scholars based in Denmark, United States and Netherlands. Thor Petersen's co-authors include Egon Stenager, Ulrik Dalgas, Tove Christensen, Johannes Jakobsen, Per Soelberg Sørensen, Thorsten Ingemann-Hansen, Kristian Overgaard, Nils Koch‐Henriksen, Anné Møller-Larsen and Mads Ravnborg and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Thor Petersen

114 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thor Petersen Denmark 33 2.0k 621 564 536 490 118 3.5k
Elisabeth Gulowsen Celius Norway 34 2.3k 1.2× 544 0.9× 540 1.0× 1.0k 1.9× 494 1.0× 127 3.5k
Eleonora Cocco Italy 32 2.1k 1.1× 506 0.8× 746 1.3× 641 1.2× 455 0.9× 238 4.1k
Marie D’hooghe Belgium 33 2.1k 1.0× 296 0.5× 508 0.9× 604 1.1× 620 1.3× 107 3.3k
Simon Broadley Australia 30 1.8k 0.9× 563 0.9× 1.2k 2.1× 519 1.0× 357 0.7× 108 3.3k
Yves Lapierre Canada 31 1.9k 1.0× 370 0.6× 730 1.3× 442 0.8× 484 1.0× 58 3.9k
Walter Hader Canada 36 2.2k 1.1× 699 1.1× 1.3k 2.3× 823 1.5× 1.1k 2.3× 101 5.4k
Bonnie I. Glanz United States 31 2.2k 1.1× 566 0.9× 732 1.3× 313 0.6× 321 0.7× 110 3.3k
Nils Koch‐Henriksen Denmark 37 3.7k 1.9× 1.0k 1.6× 959 1.7× 973 1.8× 416 0.8× 93 4.8k
Daniel Wynn United States 26 2.7k 1.4× 653 1.1× 1.1k 2.0× 792 1.5× 278 0.6× 50 3.6k
Jelena Drulović Serbia 37 3.2k 1.6× 929 1.5× 1.2k 2.2× 752 1.4× 407 0.8× 174 4.7k

Countries citing papers authored by Thor Petersen

Since Specialization
Citations

This map shows the geographic impact of Thor Petersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thor Petersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thor Petersen more than expected).

Fields of papers citing papers by Thor Petersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thor Petersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thor Petersen. The network helps show where Thor Petersen may publish in the future.

Co-authorship network of co-authors of Thor Petersen

This figure shows the co-authorship network connecting the top 25 collaborators of Thor Petersen. A scholar is included among the top collaborators of Thor Petersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thor Petersen. Thor Petersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michel, J.-P., Francesco Monti, Fabien Lamoureux, et al.. (2025). Unraveling Ceftriaxone Dosing: Free Drug Prediction, Threshold Optimization, and Model Validation. The AAPS Journal. 27(2). 50–50.
2.
3.
4.
Boix, Fernando, Jørgen Bo Hasselstrøm, Lambert K. Sørensen, et al.. (2023). Pharmacokinetics and pharmacodynamics of cannabis‐based medicine in a patient population included in a randomized, placebo‐controlled, clinical trial. Clinical and Translational Science. 17(1). e13685–e13685. 11 indexed citations
5.
Riemenschneider, Morten, Lars G. Hvid, Steffen Ringgaard, et al.. (2021). Study protocol: randomised controlled trial evaluating exercise therapy as a supplemental treatment strategy in early multiple sclerosis: the Early Multiple Sclerosis Exercise Study (EMSES). BMJ Open. 11(1). e043699–e043699. 15 indexed citations
6.
Kopp, Tine Iskov, Morten Blinkenberg, Thor Petersen, Per Soelberg Sørensen, & Melinda Magyari. (2020). Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort study. Multiple Sclerosis and Related Disorders. 40. 101956–101956. 24 indexed citations
7.
Buron, Mathias Due, Finn Sellebjerg, Jeppe Romme Christensen, et al.. (2020). Initial high-efficacy disease-modifying therapy in multiple sclerosis. Neurology. 95(8). e1041–e1051. 107 indexed citations
8.
Buron, Mathias Due, Finn Sellebjerg, Jette Lautrup Frederiksen, et al.. (2019). Comparative effectiveness of teriflunomide and dimethyl fumarate. Neurology. 92(16). e1811–e1820. 29 indexed citations
9.
Sejbæk, Tobias, Mads Nybo, Thor Petersen, & Zsolt Illés. (2018). Real-life persistence and tolerability with dimethyl fumarate. Multiple Sclerosis and Related Disorders. 24. 42–46. 28 indexed citations
10.
11.
Nexø, Bjørn A., Palle Villesen, Hanne Lindegaard, et al.. (2015). Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci. Immunologic Research. 64(1). 55–63. 33 indexed citations
12.
Laska, Magdalena Janina, Tomasz Brudek, Tove Christensen, et al.. (2012). Expression of HERV-Fc1, a Human Endogenous Retrovirus, Is Increased in Patients with Active Multiple Sclerosis. Journal of Virology. 86(7). 3713–3722. 65 indexed citations
13.
Huffman, Jeff C., Thor Petersen, Lee Baer, et al.. (2010). Outcomes Assessment in Psychiatric Postgraduate Medical Education: An Exploratory Study Using Clinical Case Vignettes. Academic Psychiatry. 34(6). 445–448. 3 indexed citations
14.
Jakobsen, Johannes, et al.. (2010). Regional brain atrophy in primary fatigued patients with multiple sclerosis. NeuroImage. 50(2). 608–615. 57 indexed citations
15.
Brudek, Tomasz, Tove Christensen, H. J. Hansen, Thor Petersen, & Anné Møller-Larsen. (2008). Synergistic Immune Responses Induced by Endogenous Retrovirus and Herpesvirus Antigens Result in Increased Production of Inflammatory Cytokines in Multiple Sclerosis Patients. Scandinavian Journal of Immunology. 67(4). 422–422. 1 indexed citations
16.
Petersen, Thor, et al.. (2007). Does Psychiatry Residency Training Reflect the "Real World" of Psychiatry Practice? A Survey of Residency Graduates. Academic Psychiatry. 31(4). 281–289. 12 indexed citations
17.
Petersen, Thor, Rebecca Harley, George I. Papakostas, et al.. (2004). Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine. Psychological Medicine. 34(3). 555–561. 22 indexed citations
18.
Petersen, Thor, et al.. (1995). RESPONSES TO MULTIPULSE MAGNETIC STIMULATION OF SPINAL NERVE ROOTS MAPPED OVER THE SACRUM IN MAN. UCL Discovery (University College London). 5 indexed citations
19.
Petersen, Thor, et al.. (1987). Bladder Neck Anesthesia and Resection in Women with Detrusor Hyperreflexia. Urologia Internationalis. 42(3). 190–194. 2 indexed citations
20.
Petersen, Thor, et al.. (1982). [Alcohol clientele in the medical outpatient department].. PubMed. 144(14). 1013–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabeth Gulowsen Celius Breakdown of academic impact, for papers by Eleonora Cocco Breakdown of academic impact, for papers by Marie D’hooghe Breakdown of academic impact, for papers by Simon Broadley Breakdown of academic impact, for papers by Yves Lapierre Breakdown of academic impact, for papers by Walter Hader Breakdown of academic impact, for papers by Bonnie I. Glanz Breakdown of academic impact, for papers by Nils Koch‐Henriksen Breakdown of academic impact, for papers by Daniel Wynn Breakdown of academic impact, for papers by Jelena Drulović
Rankless by CCL
2026